Better Health for All

Masimo's core products, including SET® pulse oximetry and Patient SafetyNet™, have demonstrated transformative health benefits, leading to a 50% reduction in unplanned transfers and 60% fewer rescue events over 3.5 years at Dartmouth-Hitchcock Medical Center,

and zero preventable deaths or brain damage due to opioid-induced respiratory depression over a 10-year period. Masimo SET® is used on over 200 million patients annually and is the primary pulse oximetry technology in all top 10 U.S. hospitals. The company's mission is to improve patient outcomes and reduce care costs. However, a recall of Rad-G Pulse Oximeters in February 2024 due to unexpected power cycling affected approximately 65 devices, was associated with 529 complaints (3% occurrence rate), and two patient deaths (causality undetermined). The company also faces concerns regarding the safety and performance of reprocessed single-use sensors, which the WHO and Joint Commission International warn against. Masimo provides direct access to its technologies for humanitarian organizations like WHO and UNICEF, and its SET® technology is designed to read accurately on all skin tones, eliminating bias. The company advocates for increased accuracy specifications and greater diversity in clinical trials, historically exceeding FDA requirements by more than 3 times for darkly pigmented subjects. Masimo's Bridge™ and Opioid Halo™ are designed to prevent overdose, and the company was the first winner of the FDA’s Opioid Innovation Challenge to have an authorized device addressing the crisis. The company's R&D is focused on breakthrough solutions like SET® pulse oximetry and rainbow® Pulse CO-Oximetry technology.

Fair Money & Economic Opportunity

Masimo Corporation is a medical technology company that develops, manufactures, and markets noninvasive patient monitoring technologies.

Its core business does not involve offering lending, deposit, or other consumer financial services. Therefore, all KPIs related to financial products, pricing, fees, lending, and wealth-building outcomes for financial clients are not applicable. The company does not generate or manage customer finance data, nor does it operate financial service access points. While Masimo engages in philanthropic activities, such as donating medical devices to families in need and providing access to humanitarian organizations, these are not financial inclusion initiatives as defined by the rubric for financial services.

Fair Pay & Worker Respect

Masimo Corporation's CEO-to-median-employee pay ratio is 157:1, with CEO Joe Kiani earning $16,511,436 and the median employee earning $105,076.

Employee engagement, based on 559 Glassdoor reviews from January 2026 to December 2025, shows an overall rating of 3.2 out of 5 stars (64%). The company has one substantiated labor-law violation in the past three years, involving a former employee's Sarbanes-Oxley Act (SOX) whistleblower claim, which is currently under appeal as of December 2024.

Honest & Fair Business

Masimo Corporation has a formal, detailed whistleblower protection policy that applies to all employees, directors, officers, and consultants worldwide.

This policy includes an anonymous toll-free hotline and website, provides protection from retaliation, and outlines procedures for reporting accounting, audit, and other compliance concerns, including fraud, errors, internal control deficiencies, misrepresentations, and violations of laws/regulations/policies. The company also has an anti-corruption policy that prohibits bribery and corruption, outlines compliance with the Foreign Corrupt Practices Act (FCPA), and requires third-party due diligence. This policy is comprehensive, covers all markets, and includes risk assessments and third-party due diligence.

Kind to Animals

Masimo Corporation is listed by CrueltyFreeInvesting.org as having "No Animal Exploitation."

This indicates a global corporate ban on all animal testing across every product category, aligning with the highest tier for animal testing policy. Consequently, this also implies that zero animals are used in any testing protocols annually.

No War, No Weapons

Masimo surveyed 496 suppliers for conflict minerals in 2020, with 425 responding.

Of these, 253 suppliers declared their materials as DRC Conflict Free. The company complies with Rule 13p-1 of the Securities Exchange Act of 1934 and Section 1502 of the Dodd-Frank Act, referencing the OECD Due Diligence Guidance and the RBA-RMI Conflict Minerals Initiative. However, Masimo has not voluntarily labeled its products "DRC conflict free" and lacks sufficient information to conclusively determine the countries of origin for all conflict minerals or whether they were from recycled/scrap sources. The report covers all products except those acquired from NantHealth in January 2020, which will be included in reporting from 2022.

Planet-Friendly Business

Masimo's total Scope 1, 2, and 3 greenhouse gas emissions were 904,065 tCO₂e in 2022, with Scope 1 and 2 emissions reduced by 23.2% from a 2019 baseline.

However, total Scope 1, 2, and 3 emissions increased from 901,650 tCO₂e in 2019 to 904,065 tCO₂e in 2022. The company has set a net-zero target year of 2050 and has SBTi validated near-term and net-zero climate targets. Masimo aims for 50% of its suppliers by spend to have SBTi-aligned targets by 2029. In terms of renewable energy, 62% of production facilities currently use renewable energy, and 37% of the Irvine headquarters' daily power needs are met by solar, with 60% of the Neuchatel office power from solar. The company achieved a 68% electronic component recycling rate in 2023 and diverted over 640 metric tons of used sensors from landfills since 2016. Life Cycle Assessments (LCA) have been conducted for Pi5 and Pi7 earphones.

Respect for Cultures & Communities

The company has no reported cultural appropriation incidents.

No specific, concrete data points were found for other KPIs related to formal partnerships with indigenous or local community groups, revenue reinvested in local development, cultural impact assessment protocols, local employment ratios, community grievance mechanisms, FPIC participation, community governance inclusion, cultural preservation investment, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving to cultural heritage, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion.

Zero Waste & Sustainable Products

Masimo has embedded circular design principles in most product lines, eliminating 2,900 metric tons of materials from 2016-2024 due to RD sensor design changes and using software upgrades to extend device lifespan.

The company has implemented several waste reduction initiatives, including a customer program that has diverted over 640 metric tons of used sensors from landfills since its inception, and an office paper recycling program that recycles 27.3 tons annually. There are no reported waste disposal violations in the provided articles for the past three years. Material efficiency is demonstrated by RD sensors reducing waste by 84% compared to cable-based sensors. Packaging efficiency is shown by a 45% reduction in storage space needed for RD SET adult sensors and over 220,000 square meters reduction in box surface area since 2016. Masimo has company-wide waste reduction targets, including a commitment to making products and packaging more environmentally friendly.